/Companies

Cytecom

Coventry, GB · 1 known investors

Find your way into Cytecom

Sign up to see every warm intro you have to Cytecom

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cytecom team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Cytecom develops a rapid diagnostic technology that detects viable bacteria in under a minute using a patented method of Optical Electrophysiology, combining fluorescent microscopy with electrical stimulation. The technology is aimed at addressing antimicrobial resistance through faster antibiotic susceptibility testing.

Founders & leadership

DJDr. James Stratford
Dr. James StratfordCo-Founder & CTO
DMDr. Munehiro Asally
Dr. Munehiro AsallyAcademic Co-Founder

Investors · 1

Companies House · registry record

View on Companies House ↗
Registered name
CYTECOM LTD
Company number
11263781
Status
Active
Company type
Private limited company
Incorporated
20 Mar 2018
Registered office
The Venture Centre University Of Warwick Science Park, Sir William Lyons Road, Coventry, CV4 7EZ
Nature of business (SIC)
26511 — Manufacture of electronic measuring, testing etc. equipment, not for industrial process control72110 — Research and experimental development on biotechnology
Accounts
last made up to 31 Mar 2025 · next due 31 Dec 2026
Confirmation statement
last made up to 19 Mar 2026 · next due 2 Apr 2027

Current officers · 2

  • Magdalena Maria Karlikowska — director, appointed 7 Jan 2023
  • James Peter Stratford — director, appointed 20 Mar 2018

Source: Companies House public register · retrieved 4 Oct 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does Cytecom do?
Cytecom develops a rapid diagnostic technology that detects viable bacteria in under a minute using a patented method of Optical Electrophysiology, combining fluorescent microscopy with electrical stimulation. The technology is aimed at addressing antimicrobial resistance through faster antibiotic susceptibility testing.
Who founded Cytecom?
Cytecom was founded by Dr. James Stratford, Dr. Munehiro Asally.
Who are Cytecom's investors?
Cytecom's investors include Oxford Technology Management.
Where is Cytecom headquartered?
Cytecom is headquartered in Coventry, GB.